ВАЖНО! Правила приравнивания журналов, входящих в международные базы данных к журналам перечня ВАК.
Ответ на официальный запрос в ВАК журнала Кардиология.

Preview

The use of systemic immune-inflammation index to predict new onset atrial fibrillation in the context of acute coronary syndrome

https://doi.org/10.18087/cardio.2022.8.n1986

Abstract

Aim    The objectives of this study were to determine the relationship between the systemic immune-inflammation index (SII) and new onset atrial fibrillation (NOAF) in patients with acute coronary syndrome (ACS), and to assess the use of this relation, if any, to predict NOAF in the context of ACS
Material and Methods    A total of 622 patients diagnosed with ACS and followed up between September 2019 and September 2021 were included in this study. 35 (5.6 %) of these patients, suffering from NOAF, were designated as the patient group, and the remaining 577 (94.4 %) patients were designated as the control group. SII was calculated with the formula [ (platelet count x neutrophil count) / lymphocyte count] in all patients.
Results    SII was significantly increased in the NOAF group [1641 (778-4506) vs. 660 (54-2835); p<0.001. The multivariable logistic regression analysis revealed that SII [OR: 1.002, 95 %CI: 1.001–1.002, p<0.001] is one of the independent predictors for NOAF, in addition to age (p=0.003) and left atrium size (p=0.005).
Conclusion    The SII index is an independent predictor of NOAF in ACS patients. This index can be used as an easily accessible value in the clinic. Assessment of risk factors for NOAF may permit early treatment and close follow-up of patients with poor prognosis who may develop AF.

About the Authors

Muhammet Raşit Sayın
University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital
Turkey

MD

Department of Cardiology, Trabzon, Turkey



Ahmet Özderya
University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital
Turkey

MD

Department of Cardiology, Trabzon, Turkey



Ali Hakan Konuş
Bingol State Hospital
Turkey

MD

Department of Cardiology, Bingol, Turkey



Murat Gökhan Yerlikaya
University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital
Turkey

MD

Department of Cardiology, Trabzon, Turkey



Mehmet Ali Maz
University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital
Turkey

MD

Department of Cardiology, Trabzon, Turkey



Ömer Faruk Çırakoğlu
University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital
Turkey

MD

Department of Cardiology, Trabzon, Turkey



Gülay Uzun
University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital
Turkey

MD

Department of Cardiology, Trabzon, Turkey



Faruk Kara
University of Health Sciences Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital
Turkey

MD

Department of Cardiology, Trabzon, Turkey



References

1.


Review

For citations:


Sayın M.R., Özderya A., Konuş A.H., Yerlikaya M.G., Maz M.A., Çırakoğlu Ö.F., Uzun G., Kara F. The use of systemic immune-inflammation index to predict new onset atrial fibrillation in the context of acute coronary syndrome. Kardiologiia. 2022;62(8):59-64. https://doi.org/10.18087/cardio.2022.8.n1986

Views: 1306


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0022-9040 (Print)
ISSN 2412-5660 (Online)